Clinical impact of severe acute respiratory syndrome coronavirus‐2 infection on IgA nephropathy

TABLE S1. Comparison of clinical characteristics between IgA nephropathy patients with and without severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection prior to SARS-CoV-2 mRNA vaccination TABLE S2. Symptoms, time of infection, vaccine status, and treatments in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected IgA nephropathy patients FIGURE S1. Changes in estimated glomerular filtration rate, hematuria, and proteinuria values in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients with IgA nephropathy before, during, and after complete recovery from SARS-CoV-2 infection (n = 8) Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.